Pharmaceutical Business review

Caraco Pharma Q3 net sales down

For the third quarter of 2010, the company’s operating loss was $4.99m, compared to $5.07m for the same period in 2009.

Net loss was $3.04m, compared to $3.03m for the same period in 2009.

For the nine months of 2010, the company posted net sales of $268.21m, compared to $178.44m for the same period in 2009.

Caraco Pharma‘s operating loss was $5.86m for the nine month, compared to $8.87m for the same period in 2009.

The company has reported net loss of $3.33m, compared to $5.79m for the same period in 2009.